Toffoli G - Search Results

1

Role of genetic polymorphisms and mutations in colorectal cancer therapy (Review).

Aiello M, Vella N, Cannavò C, Scalisi A, Spandidos DA, Toffoli G, Buonadonna A, Libra M, Stivala F. Aiello M, et al. Among authors: toffoli g. Mol Med Rep. 2011 Mar-Apr;4(2):203-8. doi: 10.3892/mmr.2010.408. Epub 2010 Dec 16. Mol Med Rep. 2011. PMID: 21468552 Review.

2

Carboplatin in elderly patients.

Sorio R, Talamini R, Toffoli G, Lombardi D, Libra M, Veronesi A. Sorio R, et al. Among authors: toffoli g. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S35-6. doi: 10.1177/030089160208800110. Tumori. 2002. PMID: 11989919 No abstract available.

3

Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy.

Toffoli G, Gafà R, Russo A, Lanza G, Dolcetti R, Sartor F, Libra M, Viel A, Boiocchi M. Toffoli G, et al. Clin Cancer Res. 2003 Feb;9(2):743-8. Clin Cancer Res. 2003. PMID: 12576444

4

Cisplatin may be a valid alternative approach in ovarian carcinoma with carboplatin hypersensitivity. Report of three cases.

Libra M, Sorio R, Buonadonna A, Berretta M, Stefanovski P, Toffoli G, Mazzaglia G, Cordani N, Stivala F, Boiocchi M. Libra M, et al. Among authors: toffoli g. Tumori. 2003 May-Jun;89(3):311-3. doi: 10.1177/030089160308900315. Tumori. 2003. PMID: 12908789

5

Thymidylate synthetase mRNA levels are increased in liver metastases of colorectal cancer patients resistant to fluoropyrimidine-based chemotherapy.

Libra M, Navolanic PM, Talamini R, Cecchin E, Sartor F, Tumolo S, Masier S, Travali S, Boiocchi M, Toffoli G. Libra M, et al. Among authors: toffoli g. BMC Cancer. 2004 Mar 25;4:11. doi: 10.1186/1471-2407-4-11. BMC Cancer. 2004. PMID: 15040806 Free PMC article.

6

UGT1A1*28 polymorphism in ovarian cancer patients.

Cecchin E, Russo A, Corona G, Campagnutta E, Martella L, Boiocchi M, Toffoli G. Cecchin E, et al. Among authors: toffoli g. Oncol Rep. 2004 Aug;12(2):457-62. Oncol Rep. 2004. PMID: 15254716

7

Tailored therapy of colorectal cancer: results, challenges and future directions.

Gasparini G, Longo R, Torino F, Barone C, Toffoli G. Gasparini G, et al. Among authors: toffoli g. Cancer J. 2005 May-Jun;11(3):175-88. doi: 10.1097/00130404-200505000-00002. Cancer J. 2005. PMID: 16053659 Review.

8

Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuclear cells is a predictive marker of the irinotecan to SN38 activation step in colorectal cancer patients.

Cecchin E, Corona G, Masier S, Biason P, Cattarossi G, Frustaci S, Buonadonna A, Colussi A, Toffoli G. Cecchin E, et al. Among authors: toffoli g. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6901-7. doi: 10.1158/1078-0432.CCR-05-0602. Clin Cancer Res. 2005. PMID: 16203781

9

Oral etoposide in elderly patients with advanced non small cell lung cancer: a clinical and pharmacological study.

Sorio R, Toffoli G, Crivellari D, Bearz A, Corona G, Colussi AM, Libra M, Talamini R, Veronesi A. Sorio R, et al. Among authors: toffoli g. J Chemother. 2006 Apr;18(2):188-91. doi: 10.1179/joc.2006.18.2.188. J Chemother. 2006. PMID: 16736888 Clinical Trial.

10

The role of UGT1A1*28 polymorphism in the pharmacodynamics and pharmacokinetics of irinotecan in patients with metastatic colorectal cancer.

Toffoli G, Cecchin E, Corona G, Russo A, Buonadonna A, D'Andrea M, Pasetto LM, Pessa S, Errante D, De Pangher V, Giusto M, Medici M, Gaion F, Sandri P, Galligioni E, Bonura S, Boccalon M, Biason P, Frustaci S. Toffoli G, et al. J Clin Oncol. 2006 Jul 1;24(19):3061-8. doi: 10.1200/JCO.2005.05.5400. J Clin Oncol. 2006. PMID: 16809730 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page